This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Schwarz Pharma Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Erwin Schollmayer: Innovator in Renal Health
Introduction
Erwin Schollmayer is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of medicine, particularly in the prevention of renal failure. His innovative approach has garnered attention in the medical community.
Latest Patents
Schollmayer holds a patent for a method that utilizes prostaglandin E1, E2, or their analogs to prevent renal failure induced by medical tests that utilize contrast media. This method involves administering a prostaglandin, preferably through intravenous infusion or injection, to patients at risk, such as diabetics. His patent highlights the use of a complex with α-cyclodextrin, enhancing the effectiveness of the treatment.
Career Highlights
Erwin Schollmayer is associated with Schwarz Pharma Limited, where he has been instrumental in developing innovative medical solutions. His work focuses on improving patient outcomes and advancing medical practices.
Collaborations
Some of his notable coworkers include Henry T Stratton and Tammy K Antonucci, who have collaborated with him on various projects within the company.
Conclusion
Erwin Schollmayer's contributions to renal health through his innovative patent demonstrate his commitment to improving medical practices. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile